Loading
SH
Sunlink Health Systems Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by TURNER HOWARD E, was filed 28 Nov 2023.
Sunlink Health Systems Inc: what insiders have been doing
Sunlink Health Systems Inc, classified in the Healthcare & Pharma sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). The past year has been quiet: not a single insider filing for Sunlink Health Systems Inc. The previous disclosure was published on 14 August 2025.
Looking back to 2016, when coverage begins, insiders filed 2 purchases and 40 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
101
Thresholds
n/a
Buy Volume
€24,983
2 ops. · all time
Sell Volume
€4M
40 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended June 2024 · cache
Income statement
RevenueUS$27.9M
Net income-US$1.3M-4.7% margin
Last declaration on 14 August 2025
Declarations101 total
10,000 sharesCommon StockSEC:0001137623-25-000001:1
50,000 sharesCommon StockSEC:0001247619-25-000001:1
50,000 sharesCommon StockSEC:0001247619-25-000001:2
180,000 sharesCommon StockSEC:0001247619-25-000001:3
1,600 sharesCommon StockSEC:0001247619-25-000001:4
5,000 sharesCommon StockSEC:0001137608-25-000001:1
108,051 sharesCommon StockSEC:0001247637-25-000001:0
49,422 sharesCommon StockSEC:0001247621-25-000003:0
551,244 sharesCommon StockSEC:0001247619-25-000001:0
81,601 sharesCommon StockSEC:0001137623-25-000001:0
554,562 sharesCommon StockSEC:0001137608-25-000001:0
3,000 shares@ US$0.7150.0% of flowCommon StockSEC:0001247621-25-000002:0
1,000 shares@ US$0.9680.3% of flowCommon StockSEC:0001248048-23-000003:0
Canonical exit: 22 Feb 2024 (T+90)
28,219 sharesSeries C Fractional InterestsSEC:0001248048-23-000002:1
5,000 sharesSeries C Fractional InterestsSEC:0001137608-23-000002:1
10,000 sharesSeries C Fractional InterestsSEC:0001137623-23-000002:1
50,000 sharesSeries C Fractional InterestsSEC:0001247619-23-000002:1
50,000 sharesSeries C Fractional InterestsSEC:0001247619-23-000002:2
180,000 sharesSeries C Fractional InterestsSEC:0001247619-23-000002:3
1,600 sharesSeries C Fractional InterestsSEC:0001247619-23-000002:4
108,051 sharesSeries C Fractional InterestsSEC:0001247637-23-000002:0
46,422 sharesSeries C Fractional InterestsSEC:0001247621-23-000002:0
551,244 sharesSeries C Fractional InterestsSEC:0001247619-23-000002:0
554,562 sharesSeries C Fractional InterestsSEC:0001137608-23-000002:0
81,601 sharesSeries C Fractional InterestsSEC:0001137623-23-000002:0
25 of 101 declarations
About Sunlink Health Systems Inc
SunLink Health Systems, Inc. is a U.S.-listed healthcare company traded on the NYSE American market under the ticker SSY. The company is headquartered in Atlanta, Georgia, United States. Its current operating footprint is relatively narrow and is built around two core businesses: healthcare services assets in the southeastern United States, historically centered on hospital- and clinic-related properties in Mississippi, and a pharmacy business in Louisiana operated through Carmichael’s Cashway Pharmacy. The latest SEC annual report also identifies a Georgia-based technology subsidiary, SunLink Health Systems Technology, which provides IT services to smaller healthcare providers. ([sec.gov](https://www.sec.gov/Archives/edgar/data/96793/000095017024110311/ssy-20240630.htm))
From a historical perspective, SunLink is not a newly formed vehicle. Its corporate documents refer to a prior identity as KRUG International Corp., highlighting a long corporate history that has included multiple legal and structural changes over time. For investors, however, the more relevant issue is the company’s present strategic posture: management and the board have repeatedly emphasized extraordinary corporate transactions, asset sales, and the pursuit of a merger or other strategic alternative. The 2024 10-K explicitly states that the board believes management should actively pursue one or more extraordinary transactions, including a merger with a compatible third party. ([sec.gov](https://www.sec.gov/Archives/edgar/data/96793/000095017024110311/ssy-20240630.htm))
Read moreShow less
In competitive terms, SunLink remains a micro-cap style healthcare platform with limited geographic scale and a concentrated asset base. Its presence is mainly in the southeastern United States, especially Mississippi, Louisiana, and Georgia. That smaller footprint gives the company some strategic flexibility, but it also leaves it exposed to reimbursement pressure, regulation, operating leverage, and capital constraints that are generally more manageable for larger hospital systems and national pharmacy chains. The company’s filings also highlight risks tied to government and private reimbursement, pharmacy regulation, and competition for healthcare asset acquisitions. ([sec.gov](https://www.sec.gov/Archives/edgar/data/96793/000095017024110311/ssy-20240630.htm))
SunLink’s service mix combines localized medical care assets, retail and specialty pharmacy operations, and ancillary IT support services for healthcare clients. This makes the business model more opportunistic than diversified in the classic sense: value creation depends heavily on asset rationalization, operational improvement, and transaction execution. Recent company news has been dominated by portfolio changes in Mississippi, including the sale of Trace-related assets, and, more importantly, the announcement and subsequent amendments of a merger agreement with Regional Health Properties in 2025. For market participants following SEC Form 4 insider activity, this corporate-action backdrop is important because it frames insider transactions within a broader strategic transformation rather than a stable standalone operating story. ([sec.gov](https://www.sec.gov/Archives/edgar/data/96793/000095017024110311/ssy-20240630.htm))
